Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

NCT00033696 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

BIOLOGICAL: filgrastim
DRUG: carboplatin
DRUG: etoposide
DRUG: paclitaxel
DRUG: topotecan hydrochloride
RADIATION: radiation therapy

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]